1. |
中華人民共和國衛生部. 衛生部辦公廳關于加強多重耐藥菌醫院感染控制工作的通知[EB/OL]. (2008-07-15)[2013-02-04]. http://www.moh.gov.cn/pygj/s3593/200807/7858200369d349b38961902ad5b37778.shtml.
|
2. |
Murray RJ, Lim TT, Pearson JC, et al. Community-onset methicillin-resistant Staphylococcus aureus bacteremia in Northern Australia[J].Int J Infect Dis, 2004, 8(5): 275-283.
|
3. |
中華人民共和國衛生部. 醫院感染診斷標準(試行)[J].中華醫學雜志, 2001, 81(5): 314-320.
|
4. |
李家泰, 齊慧敏, 李耘. 2002-2003年中國醫院和社區獲得性感染革蘭氏陽性細菌耐藥監測研究[J]. 中華檢驗醫學雜志, 2005, 28(3): 254-265.
|
5. |
Yerino GA, Vazquez MS, Magneres C, et al. Characterization of community-acquired Staphylococcus aureus methicillin-resistant (CA-MRSA) vs methicillin susceptible Staphylococcus aureus (CA-MSSA) infection (Inf) in Argentinean children[J]. Int J Infect Dis, 2010, 14(Suppl 1): 396.
|
6. |
Huang YC, Chen CJ. Community-associated methicillin-resistant Staphylococcus aureus in children in Taiwan, 2000s[J]. Int J Antimicrob Agents, 2011, 38(1): 2-8.
|
7. |
朱錦宏, 王瑤瑤, 金小珍. 新生兒大腸埃希菌敗血癥的藥敏分析及ESBLs基因分型[J]. 中華醫院感染學雜志, 2012, 22(12): 2495-2497.
|
8. |
Kang CI, Song JH, Chung DR, et al. Risk factors and treatment outcomes of community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli[J]. Int J Antimicroh Agents, 2010, 36(3): 284-287..
|
9. |
Laupland KB, Church DL, Vidakovich J, et al. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel[J]. J Infect, 2008, 57(6): 441-448..
|
10. |
賈會學, 賈建俠, 李六億, 等.某綜合醫院多重耐藥菌社區發生感染的現狀調查[J].中國感染控制雜志, 2012, 1(1): 21-24..
|